tacrolimus

Tacrolimus is a lipid of Polyketides (PK) class. Tacrolimus is associated with abnormalities such as Renal glomerular disease. The involved functions are known as inhibitors, Fungicidal activity, Metabolic Inhibition, Excretory function and Dephosphorylation. Tacrolimus often locates in Hepatic, Mitochondrial matrix and Inner mitochondrial membrane. The associated genes with Tacrolimus are RHOA gene and BGN gene.

Cross Reference

Introduction

To understand associated biological information of tacrolimus, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with tacrolimus?

tacrolimus is suspected in Renal glomerular disease, Candidiasis, Mycoses, PARKINSON DISEASE, LATE-ONSET, Morphologically altered structure, Skin Diseases, Infectious and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with tacrolimus

MeSH term MeSH ID Detail
Cardiomegaly D006332 31 associated lipids
Liver Diseases D008107 31 associated lipids
Neurodegenerative Diseases D019636 32 associated lipids
Diarrhea D003967 32 associated lipids
Stroke D020521 32 associated lipids
Ventricular Dysfunction, Left D018487 33 associated lipids
Memory Disorders D008569 33 associated lipids
Peripheral Nervous System Diseases D010523 33 associated lipids
Uremia D014511 33 associated lipids
Spinal Cord Injuries D013119 34 associated lipids
Per page 10 20 50 100 | Total 613

PubChem Associated disorders and diseases

What pathways are associated with tacrolimus

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with tacrolimus?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with tacrolimus?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with tacrolimus?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with tacrolimus?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with tacrolimus?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with tacrolimus

Download all related citations
Per page 10 20 50 100 | Total 15051
Authors Title Published Journal PubMed Link
Senatorski G et al. [New immune suppressants: topical immunomodulatory agents]. 2002 Prz. Lek. pmid:12715720
Fujine K et al. FR252921, a novel immunosuppressive agent isolated from Pseudomonas fluorescens no. 408813 III. In vivo activities. 2003 J. Antibiot. pmid:12715863
Nakamura Y et al. Acceptance of islet allografts in the liver of mice by blockade of an inducible costimulator. 2003 Transplantation pmid:12717187
Qi S et al. Significant prolongation of renal allograft survival by delayed combination therapy of FK778 with tacrolimus in nonhuman primates. 2003 Transplantation pmid:12717189
Haririan A et al. Polyomavirus reactivation in native kidneys of pancreas alone allograft recipients. 2003 Transplantation pmid:12717201
Gonwa T et al. Randomized trial of tacrolimus in combination with sirolimus or mycophenolate mofetil in kidney transplantation: results at 6 months. 2003 Transplantation pmid:12717205
Tzakis AG et al. Preliminary experience with campath 1H (C1H) in intestinal and liver transplantation. 2003 Transplantation pmid:12717207
Dresske B et al. WOFIE synergizes with calcineurin-inhibitor treatment and early steroid withdrawal in kidney transplantation. 2003 Transplantation pmid:12717217
Eason JD et al. Steroid-free liver transplantation using rabbit antithymocyte globulin and early tacrolimus monotherapy. 2003 Transplantation pmid:12717237
Stütz A et al. [Development and pre-clinical aspects of pimecrolimus]. 2003 Hautarzt pmid:12719859
Ständer S and Luger TA [Antipruritic effects of pimecrolimus and tacrolimus]. 2003 Hautarzt pmid:12719860
Thaçi D [Long term management of childhood atopic dermatitis with calcineurin inhibitors]. 2003 Hautarzt pmid:12719861
Meurer M and Wozel G [The treatment of atopic dermatitis in adults with topical calcineurin inhibitors]. 2003 Hautarzt pmid:12719862
Lübbe J [Practice experience with topical calcineurin inhibitors]. 2003 Hautarzt pmid:12719863
Quatresooz P et al. [Medication of the month. Topical pimecrolimus (Elidel)]. 2003 Rev Med Liege pmid:12723511
Schneider BL et al. Prevention of the initial host immuno-inflammatory response determines the long-term survival of encapsulated myoblasts genetically engineered for erythropoietin delivery. 2003 Mol. Ther. pmid:12727114
Akamaru Y et al. Ex vivo and systemic transfer of adenovirus-mediated CTLA4Ig gene combined with a short course of FK506 therapy prolongs islet graft survival. 2003 Jan-Mar Transpl. Immunol. pmid:12727480
Meller R et al. Seizure-like activity leads to the release of BAD from 14-3-3 protein and cell death in hippocampal neurons in vitro. 2003 Cell Death Differ. pmid:12728252
Antin JH et al. Sirolimus, tacrolimus, and low-dose methotrexate for graft-versus-host disease prophylaxis in mismatched related donor or unrelated donor transplantation. 2003 Blood pmid:12730113
Rustin M Tacrolimus ointment for the management of atopic dermatitis. 2003 Hosp Med pmid:12731133
Lanzetta M et al. Effect of FK506 and basic fibroblast growth factor on nerve regeneration using a polytetrafluoroethylene chamber for nerve repair. 2003 Jan-Mar Int Surg pmid:12731731
Mahakunakorn P et al. Cytoprotective and cytotoxic effects of curcumin: dual action on H2O2-induced oxidative cell damage in NG108-15 cells. 2003 Biol. Pharm. Bull. pmid:12736521
Bjøro K et al. Secondary osteoporosis in liver transplant recipients: a longitudinal study in patients with and without cholestatic liver disease. 2003 Scand. J. Gastroenterol. pmid:12737449
Claas FH Towards clinical transplantation tolerance. 2003 Lancet pmid:12737855
Starzl TE et al. Tolerogenic immunosuppression for organ transplantation. 2003 Lancet pmid:12737859
Lotery HE and Galask RP Erosive lichen planus of the vulva and vagina. 2003 Obstet Gynecol pmid:12738123
Burke GW Foreword. 2003 Nephrol. Dial. Transplant. pmid:12738755
First MR Renal function as a predictor of long-term graft survival in renal transplant patients. 2003 Nephrol. Dial. Transplant. pmid:12738756
Jurewicz WA Tacrolimus versus cyclosporin immunosuppression: long-term outcome in renal transplantation. 2003 Nephrol. Dial. Transplant. pmid:12738757
Undre NA Pharmacokinetics of tacrolimus-based combination therapies. 2003 Nephrol. Dial. Transplant. pmid:12738758
Yang HC Tailoring tacrolimus-based immunotherapy in renal transplantation. 2003 Nephrol. Dial. Transplant. pmid:12738759
Parrilli G et al. Effect of chronic administration of tacrolimus and cyclosporine on human gastrointestinal permeability. 2003 Liver Transpl. pmid:12740791
Jiang W et al. Synergistic effect of vincristine with tacrolimus or sirolimus in prevention of acute heart allograft rejection in the rat. 2003 Microsurgery pmid:12740883
Gerbase MW et al. Pharmacokinetics of mycophenolic acid associated with calcineurin inhibitors: long-term monitoring in stable lung recipients with and without cystic fibrosis. 2003 J. Heart Lung Transplant. pmid:12742423
Calne RY The development of immunosuppression: the rapamycin milestone. 2003 Transplant. Proc. pmid:12742463
El-Sabrout R et al. Sirolimus in combination with tacrolimus or mycophenolate mofetil for minimizing acute rejection risk in renal transplant recipients--a single center experience. 2003 Transplant. Proc. pmid:12742474
Formica RN et al. Sirolimus-based immunosuppression with reduce dose cyclosporine or tacrolimus after renal transplantation. 2003 Transplant. Proc. pmid:12742475
Lo A et al. Observations on the use of sirolimus and tacrolimus in high-risk renal transplant recipients. 2003 Transplant. Proc. pmid:12742477
Russ GR et al. Reduced and standard target concentration tacrolimus with sirolimus in renal allograft recipients. 2003 Transplant. Proc. pmid:12742480
Flechner SM Minimizing calcineurin inhibitor drugs in renal transplantation. 2003 Transplant. Proc. pmid:12742481
Wiseman AC et al. Fixed-dose sirolimus with reduced dose calcineurin inhibitor: the University of Colorado experience. 2003 Transplant. Proc. pmid:12742482
Holt DW et al. Therapeutic monitoring of sirolimus: its contribution to optimal prescription. 2003 Transplant. Proc. pmid:12742490
Trotter JF Sirolimus in liver transplantation. 2003 Transplant. Proc. pmid:12742496
MacDonald AS Rapamycin in combination with cyclosporine or tacrolimus in liver, pancreas, and kidney transplantation. 2003 Transplant. Proc. pmid:12742497
Neff GW et al. Ten years of sirolimus therapy in orthotopic liver transplant recipients. 2003 Transplant. Proc. pmid:12742498
Eichenfield LF and Beck L Elidel (pimecrolimus) cream 1%: a nonsteroidal topical agent for the treatment of atopic dermatitis. 2003 J. Allergy Clin. Immunol. pmid:12743593
Hubler TR et al. The FK506-binding immunophilin FKBP51 is transcriptionally regulated by progestin and attenuates progestin responsiveness. 2003 Endocrinology pmid:12746298
Merlino C et al. [Epstein Barr viral load monitoring in mononuclear lymphocytes and serum of renal transplant recipients using a quantitative PCR protocol]. 2003 Mar-Apr G Ital Nefrol pmid:12746803
Bunetel L et al. An unusual oral chronic graft-versus-host disease-like syndrome following a liver transplant. 2003 J. Periodontol. pmid:12747462
Mengel M et al. Incidence of polyomavirus-nephropathy in renal allografts: influence of modern immunosuppressive drugs. 2003 Nephrol. Dial. Transplant. pmid:12748354
Moons P et al. Health-related quality of life and symptom experience in tacrolimus-based regimens after renal transplantation: a multicentre study. 2003 Transpl. Int. pmid:12748758
Wencker D et al. A mechanistic role for cardiac myocyte apoptosis in heart failure. 2003 J. Clin. Invest. pmid:12750399
Mcauliffe EP Is tacrolimus the best therapy for atopic dermatitis? 2003 Am Fam Physician pmid:12751651
Chambers CA Topical tacrolimus for cutaneous lupus erythematosus. 2003 Br. J. Dermatol. pmid:12752154
Vecchietti G et al. Topical tacrolimus (FK506) for relapsing erosive stomatitis in paraneoplastic pemphigus. 2003 Br. J. Dermatol. pmid:12752158
Woodward RS et al. Incidence and cost of new onset diabetes mellitus among U.S. wait-listed and transplanted renal allograft recipients. 2003 Am. J. Transplant. pmid:12752315
Reid DW et al. Microangiopathic haemolytic anaemia and thrombocytopenia following lung volume reduction surgery in a single lung transplant recipient on maintenance tacrolimus (FK506) therapy. 2003 Respirology pmid:12753543
Baumgart DC et al. Rescue therapy with tacrolimus is effective in patients with severe and refractory inflammatory bowel disease. 2003 Aliment. Pharmacol. Ther. pmid:12755840
Neu AM et al. Tacrolimus vs. cyclosporine A as primary immunosuppression in pediatric renal transplantation: a NAPRTCS study. 2003 Pediatr Transplant pmid:12756047
Rajwal SR et al. Use of basiliximab in pediatric liver transplantation for Langerhans cell histiocytosis. 2003 Pediatr Transplant pmid:12756053
Travis LB et al. Successful treatment of vitiligo with 0.1% tacrolimus ointment. 2003 Arch Dermatol pmid:12756092
Lepe V et al. A double-blind randomized trial of 0.1% tacrolimus vs 0.05% clobetasol for the treatment of childhood vitiligo. 2003 Arch Dermatol pmid:12756094
Plettenberg H et al. Childhood vitiligo and tacrolimus: immunomodulating treatment for an autoimmune disease. 2003 Arch Dermatol pmid:12756103
Lübbe J et al. Adults with atopic dermatitis and herpes simplex and topical therapy with tacrolimus: what kind of prevention? 2003 Arch Dermatol pmid:12756112
Oetjen E et al. Inhibition of human insulin gene transcription by the immunosuppressive drugs cyclosporin A and tacrolimus in primary, mature islets of transgenic mice. 2003 Mol. Pharmacol. pmid:12761338
Waechter F Drug company accused of breaking advertising regulations. 2003 BMJ pmid:12763970
Taylor PJ and Morris RG Tacrolimus measurement by microparticle enzyme immunoassay II. 2003 Ther Drug Monit pmid:12766549
Beppu K et al. Inhibition of interferon-gamma-activated nuclear factor-kappa B by cyclosporin A: A possible mechanism for synergistic induction of apoptosis by interferon-gamma and cyclosporin A in gastric carcinoma cells. 2003 Biochem. Biophys. Res. Commun. pmid:12767900
Elad S et al. Topical tacrolimus--a novel treatment alternative for cutaneous chronic graft-versus-host disease. 2003 Transpl. Int. pmid:12768230
Klettner A and Herdegen T FK506 and its analogs - therapeutic potential for neurological disorders. 2003 Curr Drug Targets CNS Neurol Disord pmid:12769796
New treatment options for atopic dermatitis. 2003 Mayo Clin Health Lett pmid:12772683
French AE et al. Milk transfer and neonatal safety of tacrolimus. 2003 Ann Pharmacother pmid:12773068
Charpentier B Tacrolimus in renal transplantation. A review of recent data. 2003 Minerva Urol Nefrol pmid:12773964
van Duijnhoven EM et al. Metabolic aspects of tacrolimus in renal transplantation. Consequences for the choice of an immunosuppressive regimen and for the management of post-transplant diabetes mellitus. 2003 Minerva Urol Nefrol pmid:12773965
Kang S et al. Safe treatment of head/neck AD with tacrolimus ointment. 2003 J Dermatolog Treat pmid:12775315
Diem HV et al. Pediatric liver transplantation for biliary atresia: results of primary grafts in 328 recipients. 2003 Transplantation pmid:12777858
Torres A et al. [Bone metabolism alterations after kidney transplantation]. 2003 Nefrologia pmid:12778868
Pirenne J et al. Steroid-free immunosuppression during and after liver transplantation--a 3-yr follow-up report. 2003 Clin Transplant pmid:12780665
Hathaway D et al. The first report from the patient outcomes registry for transplant effects on life (PORTEL): differences in side-effects and quality of life by organ type, time since transplant and immunosuppressive regimens. 2003 Clin Transplant pmid:12780666
Oflaz H et al. The effect of calcineurin inhibitors on endothelial function in renal transplant recipients. 2003 Clin Transplant pmid:12780670
Kuypers DR et al. The use of an anti-CD25 monoclonal antibody and mycophenolate mofetil enables the use of a low-dose tacrolimus and early withdrawal of steroids in renal transplant recipients. 2003 Clin Transplant pmid:12780674
Berengue JI et al. Two- to three-fold increase in blood tacrolimus (FK506) levels during diarrhea in liver-transplanted children. 2003 Clin Transplant pmid:12780676
Tomi NS and Luger TA The treatment of atopic dermatitis with topical immunomodulators. 2003 May-Jun Clin. Dermatol. pmid:12781439
Greig P et al. Early steroid withdrawal after liver transplantation: the Canadian tacrolimus versus microemulsion cyclosporin A trial: 1-year follow-up. 2003 Liver Transpl. pmid:12783400
Arnette D et al. Regulation of ERK1 and ERK2 by glucose and peptide hormones in pancreatic beta cells. 2003 J. Biol. Chem. pmid:12783880
Pascu M et al. Rescue therapy with tacrolimus in a patient with toxic megacolon. 2003 Int J Colorectal Dis pmid:12785330
Courjaret R et al. Two distinct calcium-sensitive and -insensitive PKC up- and down-regulate an alpha-bungarotoxin-resistant nAChR1 in insect neurosecretory cells (DUM neurons). 2003 Eur. J. Neurosci. pmid:12786968
Ferrand-Drake M et al. Cyclosporin A prevents calpain activation despite increased intracellular calcium concentrations, as well as translocation of apoptosis-inducing factor, cytochrome c and caspase-3 activation in neurons exposed to transient hypoglycemia. 2003 J. Neurochem. pmid:12787063
Assmann T et al. Tacrolimus ointment for the treatment of vulvar lichen sclerosus. 2003 J. Am. Acad. Dermatol. pmid:12789187
Schroer B and Lockey R Oral tacrolimus for severe recalcitrant atopic eczema. 2003 J. Allergy Clin. Immunol. pmid:12789248
Pimecrolimus cream for atopic dermatitis. 2003 Drug Ther Bull pmid:12789846
Scott LJ et al. Tacrolimus: a further update of its use in the management of organ transplantation. 2003 Drugs pmid:12790696
King-Biggs MB et al. Airway anastomotic dehiscence associated with use of sirolimus immediately after lung transplantation. 2003 Transplantation pmid:12792493
Vu MD et al. Combination therapy of malononitrilamide FK778 with tacrolimus on cell proliferation assays and in rats receiving renal allografts. 2003 Transplantation pmid:12792496
Tzakis AG et al. Alemtuzumab (Campath-1H) combined with tacrolimus in intestinal and multivisceral transplantation. 2003 Transplantation pmid:12792506
Koenen HJ et al. Superior T-cell suppression by rapamycin and FK506 over rapamycin and cyclosporine A because of abrogated cytotoxic T-lymphocyte induction, impaired memory responses, and persistent apoptosis. 2003 Transplantation pmid:12792519
Hasegawa S et al. Combination use of suboptimal dose of FK 506 and cyclosporine in canine lung transplantation. 1992 J. Thorac. Cardiovasc. Surg. pmid:1279319
Wilasrusmee C et al. Morphological and biochemical effects of immunosuppressive drugs in a capillary tube assay for endothelial dysfunction. 2003 Clin Transplant pmid:12795661
Shaffer D et al. A pilot protocol of a calcineurin-inhibitor free regimen for kidney transplant recipients of marginal donor kidneys or with delayed graft function. 2003 Clin Transplant pmid:12795665
Stratta RJ et al. Long-term experience with simultaneous kidney-pancreas transplantation with portal-enteric drainage and tacrolimus/mycophenolate mofetil-based immunosuppression. 2003 Clin Transplant pmid:12795673